Anthony Holmes

Anthony Holmes is an accomplished executive with extensive experience in the medical technology and biotechnology sectors. As Chief Product Officer at adsilico Limited and Chief Executive Officer & Co-founder of Dominion Biotech, Anthony is at the forefront of innovative cancer drug screening solutions. Previously, Anthony served as Managing Director at Rinicare and held significant roles at Manchester Imaging Limited, where engagement with strategic partners for dental AI software commercialization took place. With a solid background in operations and business development from tenures at Optasia Medical and Image Metrics, Anthony has demonstrated expertise in transitioning companies and driving growth. Educational qualifications include a PhD in Computer Vision for Mammography and various degrees in Physics and Molecular Engineering from esteemed institutions, including The University of Manchester and Université Grenoble Alpes.